Literature DB >> 10889795

Visceral fat and insulin resistance--causative or correlative?

K N Frayn1.   

Abstract

The association between abdominal fat accumulation and risk of chronic diseases, including type II diabetes and coronary heart disease, has long been recognized. Insulin resistance may be a key factor in this link. Many studies have pointed to an association between insulin resistance and intra-abdominal fat accumulation (visceral obesity). However there is no clear proof of a causal link between visceral fat accumulation and insulin resistance. In assessing the probability of a causal link, it is useful to consider potential mechanisms. One such potential causal link is the release of non-esterified fatty acids from visceral fat into the portal vein, so that they have direct effects on hepatic metabolism. Visceral fat has been shown in many studies to exhibit a high rate of lipolysis compared with subcutaneous fat depots. However, if the idea that visceral fat releases fatty acids into the portal vein at a high rate is examined critically, a number of difficulties appear. Not least of these is the fact that continued high rates of lipolysis should lead to the disappearance of the visceral fat depot, unless these high rates of fat mobilization are matched by high rates of fat deposition. There is far less evidence for high rates of fat deposition in visceral adipose tissue, and some contrary evidence. Evidence for high rates of visceral lipolysis in vivo from studies involving catheterization of the portal vein is not strong. If this potential link is discounted, then other reasons for the relationship between visceral fat and insulin resistance must be considered. One is that there is no direct causal link, but both co-correlate with some other variable. A possibility is that this other variable is subcutaneous abdominal fat, which usually outweighs intra-abdominal fat several-fold. Subcutaneous fat probably plays the major role in determining systemic plasma non-esterified fatty acid concentrations, which are relevant in determining insulin resistance. In conclusion, there is at present no proof of a causal link between visceral fat accumulation and insulin resistance, or the associated metabolic syndrome. The possibility of co-correlation with some other factor, such as subcutaneous abdominal fat accumulation, must not be forgotten.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10889795     DOI: 10.1017/s0007114500000982

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  93 in total

1.  Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults.

Authors:  Elisa Fabbrini; Robyn A Tamboli; Faidon Magkos; Pamela A Marks-Shulman; Aaron W Eckhauser; William O Richards; Samuel Klein; Naji N Abumrad
Journal:  Gastroenterology       Date:  2010-05-07       Impact factor: 22.682

2.  Ultrasound evaluation of visceral and subcutaneous fat reduction in morbidly obese subjects undergoing laparoscopic gastric banding, sleeve gastrectomy, and Roux-en-Y gastric bypass: a prospective comparison study.

Authors:  Ido Mizrahi; Nahum Beglaibter; Natalia Simanovsky; Natali Lioubashevsky; Haggi Mazeh; Muhammad Ghanem; Katya Chapchay; Ahmed Eid; Ronit Grinbaum
Journal:  Obes Surg       Date:  2015-06       Impact factor: 4.129

Review 3.  The epidemiology of lifestyle and risk for type 2 diabetes.

Authors:  Rob M van Dam
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 4.  Abdominal adipose tissue distribution and metabolic risk.

Authors:  Suzy Wong; Ian Janssen; Robert Ross
Journal:  Sports Med       Date:  2003       Impact factor: 11.136

5.  Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects.

Authors:  H B Holt; S H Wild; P J Wood; J Zhang; A A Darekar; K Dewbury; R B Poole; R I G Holt; D I Phillips; C D Byrne
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

6.  Clinico-biochemical correlation between psoriasis and insulin resistance.

Authors:  Suparna Dhara; Anindya Dasgupta; Jayanta Kumar Rout; Ushasi Banerjee; Sayantan Dasgupta; Arindam Ghosh
Journal:  Indian J Clin Biochem       Date:  2014-01-23

Review 7.  Lipid-induced insulin resistance in the liver: role of exercise.

Authors:  Christos S Katsanos
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Clustering of metabolic syndrome components in a Middle Eastern diabetic and non-diabetic population.

Authors:  Alireza Esteghamati; Ali Zandieh; Omid Khalilzadeh; Alipasha Meysamie; Haleh Ashraf
Journal:  Diabetol Metab Syndr       Date:  2010-06-08       Impact factor: 3.320

9.  Rutaecarpine ameliorates hyperlipidemia and hyperglycemia in fat-fed, streptozotocin-treated rats via regulating the IRS-1/PI3K/Akt and AMPK/ACC2 signaling pathways.

Authors:  Xu-qiang Nie; Huai-hong Chen; Jian-yong Zhang; Yu-jing Zhang; Jian-wen Yang; Hui-jun Pan; Wen-xia Song; Ferid Murad; Yu-qi He; Ka Bian
Journal:  Acta Pharmacol Sin       Date:  2016-03-14       Impact factor: 6.150

10.  Visceral fat dominant distribution in male type 2 diabetic patients is closely related to hepatic insulin resistance, irrespective of body type.

Authors:  Yoshinori Miyazaki; Ralph A DeFronzo
Journal:  Cardiovasc Diabetol       Date:  2009-08-05       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.